U.S. flag

An official website of the United States government

NM_000535.7(PMS2):c.101G>T (p.Ser34Ile) AND not provided

Germline classification:
Uncertain significance (2 submissions)
Last evaluated:
Feb 14, 2024
Review status:
2 stars out of maximum of 4 stars
criteria provided, multiple submitters, no conflicts
Somatic classification
of clinical impact:
None
Review status:
(0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided
Somatic classification
of oncogenicity:
None
Review status:
(0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided
Record status:
current
Accession:
RCV000485924.9

Allele description [Variation Report for NM_000535.7(PMS2):c.101G>T (p.Ser34Ile)]

NM_000535.7(PMS2):c.101G>T (p.Ser34Ile)

Gene:
PMS2:PMS1 homolog 2, mismatch repair system component [Gene - OMIM - HGNC]
Variant type:
single nucleotide variant
Cytogenetic location:
7p22.1
Genomic location:
Preferred name:
NM_000535.7(PMS2):c.101G>T (p.Ser34Ile)
HGVS:
  • NC_000007.14:g.6005954C>A
  • NG_008466.1:g.8153G>T
  • NG_050738.1:g.1704C>A
  • NM_000535.7:c.101G>TMANE SELECT
  • NM_001322003.2:c.-305G>T
  • NM_001322004.2:c.-242-1896G>T
  • NM_001322005.2:c.-305G>T
  • NM_001322006.2:c.101G>T
  • NM_001322007.2:c.-115G>T
  • NM_001322008.2:c.-52-1896G>T
  • NM_001322009.2:c.-305G>T
  • NM_001322010.2:c.-242-1896G>T
  • NM_001322011.2:c.-784G>T
  • NM_001322012.2:c.-784G>T
  • NM_001322013.2:c.-305G>T
  • NM_001322014.2:c.101G>T
  • NM_001322015.2:c.-384G>T
  • NP_000526.2:p.Ser34Ile
  • NP_001308935.1:p.Ser34Ile
  • NP_001308943.1:p.Ser34Ile
  • LRG_161t1:c.101G>T
  • LRG_161:g.8153G>T
  • NC_000007.13:g.6045585C>A
  • NM_000535.5:c.101G>T
  • NM_000535.6:c.101G>T
  • NR_136154.1:n.188G>T
  • p.S34I
Protein change:
S34I
Links:
dbSNP: rs370612538
NCBI 1000 Genomes Browser:
rs370612538
Molecular consequence:
  • NM_001322003.2:c.-305G>T - 5 prime UTR variant - [Sequence Ontology: SO:0001623]
  • NM_001322005.2:c.-305G>T - 5 prime UTR variant - [Sequence Ontology: SO:0001623]
  • NM_001322007.2:c.-115G>T - 5 prime UTR variant - [Sequence Ontology: SO:0001623]
  • NM_001322009.2:c.-305G>T - 5 prime UTR variant - [Sequence Ontology: SO:0001623]
  • NM_001322011.2:c.-784G>T - 5 prime UTR variant - [Sequence Ontology: SO:0001623]
  • NM_001322012.2:c.-784G>T - 5 prime UTR variant - [Sequence Ontology: SO:0001623]
  • NM_001322013.2:c.-305G>T - 5 prime UTR variant - [Sequence Ontology: SO:0001623]
  • NM_001322015.2:c.-384G>T - 5 prime UTR variant - [Sequence Ontology: SO:0001623]
  • NM_001322004.2:c.-242-1896G>T - intron variant - [Sequence Ontology: SO:0001627]
  • NM_001322008.2:c.-52-1896G>T - intron variant - [Sequence Ontology: SO:0001627]
  • NM_001322010.2:c.-242-1896G>T - intron variant - [Sequence Ontology: SO:0001627]
  • NM_000535.7:c.101G>T - missense variant - [Sequence Ontology: SO:0001583]
  • NM_001322006.2:c.101G>T - missense variant - [Sequence Ontology: SO:0001583]
  • NM_001322014.2:c.101G>T - missense variant - [Sequence Ontology: SO:0001583]
  • NR_136154.1:n.188G>T - non-coding transcript variant - [Sequence Ontology: SO:0001619]

Condition(s)

Synonyms:
none provided
Identifiers:
MedGen: C3661900

Recent activity

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

See more...

Assertion and evidence details

Submission AccessionSubmitterReview Status
(Assertion method)
Clinical Significance
(Last evaluated)
OriginMethodCitations
SCV000565380GeneDx
criteria provided, single submitter

(GeneDx Variant Classification Process June 2021)
Uncertain significance
(Feb 14, 2024)
germlineclinical testing

Citation Link,

SCV001469597Quest Diagnostics Nichols Institute San Juan Capistrano
criteria provided, single submitter

(Quest Diagnostics criteria)
Uncertain significance
(May 18, 2023)
unknownclinical testing

PubMed (5)
[See all records that cite these PMIDs]

Summary from all submissions

EthnicityOriginAffectedIndividualsFamiliesChromosomes testedNumber TestedFamily historyMethod
not providedgermlineyesnot providednot providednot providednot providednot providedclinical testing
not providedunknownunknownnot providednot providednot providednot providednot providedclinical testing

Citations

PubMed

Patterns and functional implications of rare germline variants across 12 cancer types.

Lu C, Xie M, Wendl MC, Wang J, McLellan MD, Leiserson MD, Huang KL, Wyczalkowski MA, Jayasinghe R, Banerjee T, Ning J, Tripathi P, Zhang Q, Niu B, Ye K, Schmidt HK, Fulton RS, McMichael JF, Batra P, Kandoth C, Bharadwaj M, Koboldt DC, et al.

Nat Commun. 2015 Dec 22;6:10086. doi: 10.1038/ncomms10086.

PubMed [citation]
PMID:
26689913
PMCID:
PMC4703835

Burden of hereditary cancer susceptibility in unselected patients with pancreatic ductal adenocarcinoma referred for germline screening.

Cremin C, Lee MK, Hong Q, Hoeschen C, Mackenzie A, Dixon K, McCullum M, Nuk J, Kalloger S, Karasinska J, Scudamore C, Kim PTW, Donnellan F, Lam ECS, Lim HJ, Neben CL, Stedden W, Zhou AY, Schaeffer DF, Sun S, Renouf DJ, Schrader KA.

Cancer Med. 2020 Jun;9(11):4004-4013. doi: 10.1002/cam4.2973. Epub 2020 Apr 7.

PubMed [citation]
PMID:
32255556
PMCID:
PMC7286471
See all PubMed Citations (5)

Details of each submission

From GeneDx, SCV000565380.9

#EthnicityIndividualsChromosomes TestedFamily HistoryMethodCitations
1not providednot providednot providednot providedclinical testingnot provided

Description

Observed in individuals with personal and/or family history of breast, colorectal, pancreatic and other cancers (PMID: 26689913, 32255556, 33471991, 34326862); In silico analysis supports that this missense variant has a deleterious effect on protein structure/function; This variant is associated with the following publications: (PMID: 32255556, 26689913, 32571878, 33471991, 11574484, 34326862)

#SampleMethodObservation
OriginAffectedNumber testedTissuePurposeMethodIndividualsAllele frequencyFamiliesCo-occurrences
1germlineyesnot providednot providednot providednot providednot providednot providednot provided

From Quest Diagnostics Nichols Institute San Juan Capistrano, SCV001469597.3

#EthnicityIndividualsChromosomes TestedFamily HistoryMethodCitations
1not providednot providednot providednot providedclinical testing PubMed (5)

Description

In the published literature, this variant has been reported in an individual affected with pancreatic ductal adenocarcinoma (PDAC) (PMID: 32255556 (2020)), and as a somatic variant in a head and neck squamous cell carcinoma tumor sample (PMID: 26689913 (2015)). It has been reported in individuals with breast cancer in a breast cancer association study (PMID: 33471991 (2021), see also LOVD (http://databases.lovd.nl/shared/genes/PMS2)). One functional analysis suggested that this variant may retain ATPase and DNA-binding abilities while disrupting the structure of the N-terminal domain, but additional functional studies are needed to ascertain the global effect of this variant on gene and gene product (PMID: 32571878 (2020)). The frequency of this variant in the general population, 0.00008 (10/125392 chromosomes (Genome Aggregation Database, http://gnomad.broadinstitute.org)), is uninformative in the assessment of its pathogenicity. Analysis of this variant using bioinformatics tools for the prediction of the effect of amino acid changes on protein structure and function yielded conflicting predictions that this variant is benign or damaging. Based on the available information, we are unable to determine the clinical significance of this variant.

#SampleMethodObservation
OriginAffectedNumber testedTissuePurposeMethodIndividualsAllele frequencyFamiliesCo-occurrences
1unknownunknownnot providednot providednot providednot providednot providednot providednot provided

Last Updated: Sep 29, 2024